Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4030 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.09 USD | +2.45% | +0.48% | -19.62% | -25.62% | 69.70 M USD | ||
| 4032 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.86 USD | -2.62% | -5.10% | -9.71% | -75.36% | 69.61 M USD | ||
| 4037 |  CSBR Champions Oncology, Inc. - Common Stock | 4.98 USD | +2.05% | -1.19% | -4.05% | -24.20% | 69.31 M USD | ||
| 4040 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.54 USD | -10.00% | -16.92% | -31.65% | -57.48% | 68.86 M USD | ||
| 4044 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.36 USD | -5.26% | 0.00% | +9.09% | -72.52% | 68.35 M USD | ||
| 4050 |  XBIT XBiotech Inc. - Common Stock | 2.20 USD | +0.46% | 0.00% | +1.38% | -16.03% | 67.07 M USD | ||
| 4052 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.43 USD | -4.67% | +3.62% | +6.72% | -30.24% | 66.80 M USD | ||
| 4054 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -7.23% | -12.50% | -30.00% | 66.43 M USD | ||
| 4055 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.14 USD | -2.56% | -9.52% | -3.39% | -52.10% | 66.39 M USD | ||
| 4063 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 2.53 USD | -6.64% | -17.32% | -36.75% | -71.15% | 65.62 M USD | ||
| 4074 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.00 USD | +1.01% | -5.66% | -11.50% | -32.43% | 61.92 M USD | ||
| 4079 |  ELOX Eloxx Pharmaceuticals, Inc. | 15.18 USD | +2.02% | -4.65% | -5.01% | +51.80% | 61.27 M USD | ||
| 4081 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.38 USD | +8.57% | 0.00% | +58.33% | -81.90% | 60.68 M USD | ||
| 4084 |  GOSS Gossamer Bio, Inc. - Common Stock | 9.88 USD | -2.95% | -11.71% | +6486.67% | +287.45% | 60.37 M USD | ||
| 4089 |  RNXT RenovoRx, Inc. - Common Stock | 1.33 USD | -2.92% | -15.29% | -32.49% | +18.75% | 60.02 M USD | ||
| 4091 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 2.51 USD | -1.95% | -10.68% | -31.42% | -75.46% | 59.75 M USD | ||
| 4097 |  IBIO iBio, Inc. - Common Stock | 0.92 USD | -8.91% | -17.86% | -29.23% | -60.00% | 59.16 M USD | ||
| 4103 |  BOLD Boundless Bio, Inc. - Common Stock | 2.58 USD | -2.27% | -1.53% | -9.79% | +122.41% | 58.69 M USD | ||
| 4112 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 0.95 USD | -1.04% | -27.48% | -35.81% | -83.22% | 57.31 M USD | ||
| 4114 |  PDSB PDS Biotechnology Corporation - Common Stock | 1.02 USD | -4.67% | +43.66% | +251.72% | +2.00% | 57.09 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |